The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Pinamox 250 mg/5 ml Powder for Oral Suspension

Athlone Laboratories LtdPA0298/010/002

Main Information

Trade NamePinamox 250 mg/5 ml Powder for Oral Suspension
Active SubstancesAmoxicillin
Dosage FormPowder for oral suspension
Licence HolderAthlone Laboratories Ltd
Licence NumberPA0298/010/002

Group Information

ATC CodeJ01CA Penicillins with extended spectrum
J01CA04 amoxicillin


License statusAuthorised
Licence Issued18/05/1988
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back